INTERNATIONAL PATENT: NESTED THERAPEUTICS, INC. FILES APPLICATION FOR "CRYSTALLINE FORMS OF 3-[[3-FLUORO-2-(METHYLSULFAMOYLAMINO)-4-PYRIDYL]JMETHYL]-7-[(3-FLUORO-2-PYRIDYL)OXY]-4-METHYL-CHROMEN-2-ONE"

GENEVA, Dec. 24 -- NESTED THERAPEUTICS, INC. (1030 Massachusetts Avenue, Suite 401Cambridge, MA 02138) filed a patent application (PCT/US2025/033293) for "CRYSTALLINE FORMS OF 3-[[3-FLUORO-2-(METHYLSULFAMOYLAMINO)-4-PYRIDYL]JMETHYL]-7-[(3-FLUORO-2-PYRIDYL)OXY]-4-METHYL-CHROMEN-2-ONE" on Jun 12, 2025. With publication no. WO/2025/259841, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): STEINHUEBEL, Dietrich (c/o Nested Therapeutics, Inc.1030 Massachusetts Avenue, Suite 401Cambridge, MA 02138)

Abstract: Provided herein are ...